Eric Rose

Eric Rose

Chief Tech/Sci/R&D Officer chez MESOBLAST LIMITED

Fortune : 11 431 $ au 31/03/2024

73 ans
Health Technology
Finance
Consumer Services

Profil

Eric A.
Rose
is the founder of VTVX Holdings I LLC.
He currently holds the position of Chairman at LongView Ventures LLC.
Additionally, he is the Executive Director & Chief Medical Officer at Mesoblast Ltd., Director at Orchestra BioMed, Inc., Non-Executive Director at Orchestra Biomed Holdings, Inc., and Advisor at KBL Healthcare Ventures.
He is also a member of the Strategic Advisory Board at Broadview Ventures, Inc. In the past, he served as Chairman at SIGA Technologies, Inc., Chairman-Surgery Department at NewYork-Presbyterian Hospital, Chairman-Health Evidence & Policy Department at Icahn School of Medicine at Mount Sinai, Chairman-Surgery Department at Columbia University College of Physicians & Surgeons, and Independent Director at ABIOMED, Inc. He has also held positions as a Director at Nexell Therapeutics, Inc., Keryx Biopharmaceuticals, Inc., Nephros, Inc., CircuLite, Inc., PharmaCore, Inc., and the National Preparedness & Response Science Board.
He was the President of the International Society for Heart & Lung Transplantation and served as Executive Vice President-Life Sciences at MacAndrews & Forbes LLC and MacAndrews & Forbes Holdings, Inc. Dr. Rose received his undergraduate and doctorate degrees from Columbia University College of Physicians & Surgeons.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/03/2024 2 169 ( 0,01% ) 11 431 $ 31/03/2024
10/01/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Eric Rose

SociétésPosteDébut
MESOBLAST LIMITED Chief Tech/Sci/R&D Officer 01/02/2022
ORCHESTRA BIOMED HOLDINGS, INC. Director/Board Member 26/01/2023
LongView Ventures LLC Chairman -
Consultant / Advisor -
Director/Board Member 01/12/2018
Corporate Officer/Principal 01/01/2007
Consultant / Advisor -
Tous les postes actifs de Eric Rose

Anciens postes connus de Eric Rose

SociétésPosteFin
ABIOMED, INC. Director/Board Member 22/12/2022
SIGA TECHNOLOGIES, INC. Chief Executive Officer 13/10/2016
░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Eric Rose

Formation de Eric Rose

Columbia University College of Physicians & Surgeons Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Eric Rose

Relations

100 +

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
SIGA TECHNOLOGIES, INC.

Health Technology

NEPHROS, INC.

Health Technology

MESOBLAST LIMITED

Health Technology

ORCHESTRA BIOMED HOLDINGS, INC.

Health Technology

Entreprise privées15

Health Technology

Health Technology

Health Technology

Commercial Services

Distribution Services

International Society for Heart & Lung Transplantation

Health Services

Finance

Finance

Health Technology

Finance

Finance

National Preparedness & Response Science Board

Health Technology

LongView Ventures LLC

Voir les connexions sociétés